Biotech & Pharma News & Analysis | Business 2.0
Johnson & Johnson Reports ICOTYDE Psoriasis Trial Meets Main Endpoints
GSK Sets Out Liver Disease Research for AASLD
EMBL Explores Brain Cancer Cell States With AI and Single-Cell Technologies
Can In Vivo CAR-T Simplify Cell Therapy Manufacturing?
EMBL Images Ribosome Assembly Inside Human Cells
Ris-Rez Shows Progression-free Survival Gain in ARTEMIS-011 Osteosarcoma Trial
Johnson & Johnson Details Head and Neck Tumour Responses in OrigAMI-4
GSK Announces US Approval of Hibsago for Selected Hepatitis B Patients
Jemperli Gains US Accelerated Approval for MSI-H/dMMR Rectal Cancer
GSK Reports Early Global Lung Cancer Results for Ris-Rez
AlphaGenome Can Rank Variants Fast but Validation Still Decides
Johnson & Johnson Lifts 2026 Sales Guidance as Innovative Medicine Leads
How Synthetic Cells Could Reshape Drug Discovery With Genomics and AI
GSK Unit's Long-acting HIV Regimen Meets Phase Iiib Endpoint
Alexion to Present 16 Rare Disease Studies at ASBMR 2026
Astrazeneca Opens Kendall Square R&d Centre With $1 Billion Bet
Bayer Plans 2.2 Billion Dollar Ohio Manufacturing Site
Top 10 Biopharma Conferences In London, UK And Europe In 2026 And 2027
Astrazeneca, Daiichi Sankyo Add Summit to Datroway Combination Push
What Does Bayer's New Chief Medical Officer Appointment Signal?